Jefferies Financial Group’s Filana Therapeutics FLNA Stock Holding History

Jefferies Financial Group’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-123,600	Closed	-$292K	–	1955
2024 Q4	$292K	Hold	123,600	–	–	﹤0.01%	1270
2024 Q3	$3.64M	Buy	123,600 +6,500	+6%	+$150K	0.03%	393
2024 Q2	$1.45M	Buy	117,100 +2,200	+2%	+$46.4K	0.02%	637
2024 Q1	$2.33M	Sell	114,900 -333,700	-74%	-$7.69M	0.02%	538
2023 Q4	$10.1M	Buy	448,600 +24,200	+6%	+$511K	0.07%	221
2023 Q3	$7.06M	Sell	424,400 -8,100	-2%	-$161K	0.06%	247
2023 Q2	$10.6M	Buy	432,500 +214,600	+98%	+$5.17M	0.1%	192
2023 Q1	$5.26M	Sell	217,900 -592,700	-73%	-$16.4M	0.04%	349
2022 Q4	$23.9M	Buy	+810,600	New	+$29.1M	0.17%	96

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Financial Group's FLNA Position: Q1 2025 in Review

Jefferies Financial Group sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 23,500 shares — an estimated $55.5K sold.

Jefferies Financial Group first reported a position in FLNA in Q4 2022 and held it in 8 quarters. The position peaked at $3.94M in Q3 2023. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

Jefferies Financial Group reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
Jefferies Financial Group sold 23,500 Filana Therapeutics shares in Q1 2025, an estimated $55.5K.
Jefferies Financial Group first reported a position in Filana Therapeutics in Q4 2022 and held it in 8 quarters.
Jefferies Financial Group's Filana Therapeutics position peaked at $3.94M in Q3 2023.
117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on Jefferies Financial Group's 13F filing for Q1 2025, filed 8 May 2025.